CICC
PFE icon

Capital Investment Counsel (Colorado)’s Pfizer PFE Stock Holding History

Capital Investment Counsel (Colorado)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69,774
Closed -$2.01M – 134
2023
Q4 		$2.01M Buy
+69,774
New +$2.11M 0.76% 61

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Investment Counsel (Colorado)'s PFE Position: Q1 2024 in Review

Capital Investment Counsel (Colorado) sold out of Pfizer (PFE) in Q1 2024, closing a stake of 69,774 shares — an estimated $2.01M sold.

Capital Investment Counsel (Colorado) first reported a position in PFE in Q4 2023 and held it in 1 quarter. The position peaked at $2.01M in Q4 2023. 2,876 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Capital Investment Counsel (Colorado) reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Capital Investment Counsel (Colorado) sold 69,774 Pfizer shares in Q1 2024, an estimated $2.01M.
  • Capital Investment Counsel (Colorado) first reported a position in Pfizer in Q4 2023 and held it in 1 quarter.
  • Capital Investment Counsel (Colorado)'s Pfizer position peaked at $2.01M in Q4 2023.
  • 2,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q1 2024, filed 14 Aug 2024.